Cargando…
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
JAK-STAT (Janus associated kinase-signal transducer and activator of transcription) pathway plays a critical role in transduction of extracellular signals from cytokines and growth factors involved in hematopoiesis, immune regulation, fertility, lactation, growth and embryogenesis. JAK family contai...
Autores principales: | Furqan, Muhammad, Mukhi, Nikhil, Lee, Byung, Liu, Delong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776247/ https://www.ncbi.nlm.nih.gov/pubmed/24252238 http://dx.doi.org/10.1186/2050-7771-1-5 |
Ejemplares similares
-
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
por: Ramis-Zaldivar, Joan Enric, et al.
Publicado: (2021) -
STAT inhibitors for cancer therapy
por: Furqan, Muhammad, et al.
Publicado: (2013) -
JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023) -
Methotrexate Is a JAK/STAT Pathway Inhibitor
por: Thomas, Sally, et al.
Publicado: (2015) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)